List of Excipients in API sacubitril and valsartan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sacubitril and valsartan
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | CROSPOVIDONE | |
| Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | FERRIC OXIDE RED | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Showing 1 to 3 of 3 entries
Excipients in ANDA-approved (generic) drugs containing sacubitril and valsartan
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 | CROSPOVIDONE |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 | FERRIC OXIDE RED |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 | FERROSOFERRIC OXIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Showing 1 to 3 of 3 entries
Detailed excipient profiles for sacubitril and valsartan
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sacubitril and valsartan drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| Alembic Pharmaceuticals Limited | sacubitril and valsartan | 46708-556 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
sacubitril and valsartan drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Novadoz Pharmaceuticals LLC | sacubitril and valsartan | 72205-280 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
Excipient focus: CROSCARMELLOSE SODIUM
sacubitril and valsartan drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | sacubitril and valsartan | 72205-280 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
sacubitril and valsartan drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: CROSPOVIDONE
sacubitril and valsartan drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
sacubitril and valsartan drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | sacubitril and valsartan | 67877-707 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
Excipient focus: FERRIC OXIDE RED
sacubitril and valsartan drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
sacubitril and valsartan drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: FERRIC OXIDE YELLOW
sacubitril and valsartan drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | sacubitril and valsartan | 67877-707 |
| Aphena Pharma Solutions - Tennessee LLC | sacubitril and valsartan | 71610-806 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
sacubitril and valsartan drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: FERROSOFERRIC OXIDE
sacubitril and valsartan drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
sacubitril and valsartan drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | sacubitril and valsartan | 71610-806 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
sacubitril and valsartan drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Ascend Laboratories LLC | sacubitril and valsartan | 67877-707 |
| Aphena Pharma Solutions - Tennessee LLC | sacubitril and valsartan | 71610-806 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
sacubitril and valsartan drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| Alembic Pharmaceuticals Limited | sacubitril and valsartan | 46708-556 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: HYPROMELLOSE
sacubitril and valsartan drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | sacubitril and valsartan | 46708-556 |
| Alembic Pharmaceuticals Inc | sacubitril and valsartan | 62332-556 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
sacubitril and valsartan drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: HYPROMELLOSE 2910
sacubitril and valsartan drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| Novadoz Pharmaceuticals LLC | sacubitril and valsartan | 72205-280 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
sacubitril and valsartan drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Alembic Pharmaceuticals Limited | sacubitril and valsartan | 46708-556 |
| Alembic Pharmaceuticals Inc | sacubitril and valsartan | 62332-556 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: HYPROMELLOSES
sacubitril and valsartan drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Ascend Laboratories LLC | sacubitril and valsartan | 67877-707 |
| Aphena Pharma Solutions - Tennessee LLC | sacubitril and valsartan | 71610-806 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
sacubitril and valsartan drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| Alembic Pharmaceuticals Limited | sacubitril and valsartan | 46708-556 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
sacubitril and valsartan drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
sacubitril and valsartan drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Alembic Pharmaceuticals Limited | sacubitril and valsartan | 46708-556 |
| Alembic Pharmaceuticals Inc | sacubitril and valsartan | 62332-556 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: MAGNESIUM STEARATE
sacubitril and valsartan drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
sacubitril and valsartan drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: MICROCRYSTALLINE CELLULOSE 112
sacubitril and valsartan drug variants containing MICROCRYSTALLINE CELLULOSE 112
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Novadoz Pharmaceuticals LLC | sacubitril and valsartan | 72205-280 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
sacubitril and valsartan drug variants not containing MICROCRYSTALLINE CELLULOSE 112
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| Alembic Pharmaceuticals Limited | sacubitril and valsartan | 46708-556 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: POLYETHYLENE GLYCOL 4000
sacubitril and valsartan drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
sacubitril and valsartan drug variants not containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: POVIDONE K30
sacubitril and valsartan drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
sacubitril and valsartan drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| Alembic Pharmaceuticals Limited | sacubitril and valsartan | 46708-556 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: SILICON DIOXIDE
sacubitril and valsartan drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
sacubitril and valsartan drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
sacubitril and valsartan drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | sacubitril and valsartan | 67877-707 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
sacubitril and valsartan drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: TALC
sacubitril and valsartan drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
sacubitril and valsartan drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: TITANIUM DIOXIDE
sacubitril and valsartan drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
sacubitril and valsartan drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
